When it comes to seeking the best oncologist in Vizag or even in India, Dr B Ravi Shankar stands out as a top choice. With a specialization in Clinical Oncology, he has established himself as one of the leading experts in the field. His expertise and dedication have earned him the reputation of bein

2 views • 6 slides

Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of canc

0 views • 5 slides

Data management & integration enhancements help improve the speed & quality of drug discovery and clinical trial processes. Artificial intelligence (AI) is employed in real-world data (RWD) to enhance data anomaly detection, standardization, and quality check at the pre-processing stage. AI is expec

1 views • 3 slides

Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application (Oncology, Non-oncology) End User (Pharma, Academics, Hospitals) \u2013 Global Forecast to 2030\n

0 views • 4 slides

Real-world Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2029

2 views • 3 slides

In the field of oncology care, the importance of effective management to reduce burnout among healthcare providers is highlighted. Stress, psychosocial risks, and burnout definitions are explored, emphasizing the impact on healthcare professionals' well-being and job satisfaction. Studies reveal hig

2 views • 69 slides

Explore how the COVID-19 pandemic has spurred the adoption of telehealth in oncology, as discussed by Dr. Samantha Jaglowski from The Ohio State University. Discover the rationale, barriers, implementation strategies, and future directions for telehealth in cancer care.

3 views • 59 slides

The large share of this segment is mainly attributed to the growing amount of medical data generated in hospitals and the increasing dependence of outcome-based studies on real-world data. EHRs are the most commonly used form of healthcare database that helps in conducting outcome-based studies.

0 views • 2 slides

\n\nGemtuzumab 4.5 mg is a monoclonal antibody that targets CD33 antigen, which is found on the surface of leukemia cells. In precision oncology, this drug has been used to treat patients with acute myeloid leukemia (AML) who are deemed appropriate for this therapy. It has been shown to increase sur

1 views • 3 slides

Data management & integration enhancements help improve the speed & quality of drug discovery and clinical trial processes. Artificial intelligence (AI) is employed in real-world data (RWD) to enhance data anomaly detection, standardization, and quality check at the pre-processing stage. AI is expec

0 views • 2 slides

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. \n\nRegister Now @ \/\/events.marketsandmarkets.com\/immuno-on

1 views • 6 slides

RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post Market Surveillance), End User (Pharma, Payer, Provider) - Global Forecast to 2029

1 views • 3 slides

This module provides training on medical terminology basics for patient navigators in oncology. It covers defining terms using prefixes, root words, and suffixes, common oncology words, and available resources. Learn how to approach medical terminology effectively by understanding word roots and com

1 views • 20 slides

Lujia Chen, a Postdoc Associate at the University of Pittsburgh, focuses on developing deep learning models for precision oncology. By utilizing machine learning, especially deep learning models, Chen aims to identify cancer signaling pathways, predict drug sensitivities, and personalize cancer trea

1 views • 5 slides

Providing an overview of patient navigation in oncology, this educational material covers social determinants of health, patient navigation history, core competencies, and models in the field. Supported by the CDC, it discusses disparities in healthcare access and the impact on medically underserved

1 views • 37 slides

CADTH provided updates on its Scientific Advice program and Post-Market Drug Evaluation. CIOMS shared a report on using real-world data in decision-making. CDA-TO sought input on drug analytics. The committee discussed its mandate and membership for future meetings.

0 views • 5 slides

This content delves into the essentials of patient navigation in oncology, covering competencies, professional roles, responsibilities, and functions of patient navigators. It highlights the importance of patient empowerment, communication, cultural competency, and care coordination. The material al

0 views • 43 slides

This module delves into the fundamentals of health care navigation with a focus on oncology patients. It covers the core competencies for patient navigators, compares hospital structures, explores cancer care delivery methods, discusses inpatient and outpatient care, and highlights different types o

0 views • 32 slides

Integrative oncology blends conventional cancer treatments with mind-body practices, natural products, and lifestyle modifications to improve health, quality of life, and clinical outcomes. This approach empowers individuals to actively participate in their care journey, promoting overall well-being

0 views • 18 slides

This module focuses on Program Evaluation and Quality Improvement for Patient Navigators in oncology, covering competencies, learning objectives, definitions, and reasons for evaluation. It emphasizes the importance of evaluating programs to improve effectiveness, secure funding, meet accreditation

0 views • 39 slides

The concept of estimands in oncology clinical trials plays a crucial role in defining treatment effects and analyzing overall survival outcomes. This framework aims to enhance transparency, align trial objectives, and strengthen interdisciplinary dialogues. Introduced by the ICH E9(R1) guideline in

0 views • 14 slides

Explore the significance of social determinants of health and health disparities in the context of oncology patient navigation. Delve into the history, models, and core competencies of patient navigation while addressing the impact of medically underserved populations and cancer health disparities.

0 views • 37 slides

This educational curriculum emphasizes the importance of addressing psychiatric comorbidities in palliative care and psycho-oncology patients. It covers diagnostic challenges, evidence-based treatments, and screening for substance use disorders. The content also discusses the principles of palliativ

0 views • 53 slides

Understanding the significance of physical therapy in pediatric oncology, this resource emphasizes early screening and intervention to minimize long-term impairments for children with cancer. It covers identifying side effects of cancer treatment, typical motor development, the role of physical ther

0 views • 32 slides

Provide an overview of common Musculoskeletal (MSK) oncology pathology assessment, management principles, and preparation for FRCS. The agenda includes topics like soft tissue sarcomas, bone tumors, metastatic bone disease, vivas/cases, and guest speakers sharing valuable insights. Feedback is encou

0 views • 11 slides

This document contains contact information for various hospitals in the West Midlands offering acute oncology services, including details on advice lines, nurses, consultants, and specific cancer services. Stay informed about the hospitals in your area that provide specialist care for cancer patient

0 views • 17 slides

Explore the world of radiation therapy in oncology with insights on indications, side effects, case studies, and treatment protocols. Understand how radiation therapy works, its various types, planning procedures, dose prescription, and patient management. Delve into the essential aspects of local t

0 views • 46 slides

This document lists contact information for various hospitals in the West Midlands area related to acute oncology services, including details of 24-hour advice lines, oncology nurses, consultants, and specific cancer service leads. Updates and changes to the information should be notified via email

0 views • 17 slides

Neuro-Oncology Prehabilitation Service saw 73 new patients between Nov 2022-April 2023. Patients with high-grade gliomas, low-grade gliomas, and brain metastases received tailored interventions pre and post-surgery. Patient feedback was positive, indicating a very good overall experience. The servic

0 views • 5 slides

Real world data (RWD) includes various sources like electronic health records, claims data, and patient-generated data which inform on health status. Real world evidence (RWE) is the clinical evidence derived from RWD analysis regarding the usage and benefits/risks of medical products. Goals of RWE

0 views • 26 slides

\"The Global Hemato Oncology Testing Market Size is expected to reach USD 9.4 Billion by 2032, at a CAGR of 8.13% during the forecast period 2022 to 2032. \n\n\"\n

1 views • 5 slides

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides

Explore the shifting trends in oncology drug development, from understanding cancer mechanisms to new immuno-oncology approaches. Delve into the role of statisticians in researching cancer drugs and uncover the importance of early-phase trials in validating treatment mechanisms. Discover the need fo

0 views • 22 slides

Patient feedback for the Neuro-Oncology services at Bristol Haematology Oncology Centre reflects a consistently positive experience. Patients found the staff to be supportive, informative, attentive, caring, and empathetic. The professionalism, humanism, kindness, and generosity of the oncology team

0 views • 9 slides

Bel Mondo Beauty introduces a breakthrough Moisture Renewal Mask made from bio cellulose, a fabric with incredible skin affinity and efficient ingredient transfer. This professional series mask targets oncology spa services, developed in collaboration with Oncology Spa Solutions to care for clients

0 views • 19 slides

FDA showcases illustrative examples of how Real-World Evidence (RWE) has been utilized in regulatory decisions, highlighting its value across different submission types, data sources, and purposes from FY12-FY19. The FDA report features cases like a modified hemodialysis catheter end cap, tumor prof

0 views • 14 slides

BCG Matrix, developed by Bruce Henderson of the Boston Consulting Group, categorizes business units into Question Marks, Stars, Cash Cows, and Dogs based on market growth and relative market share. Market share and market growth are crucial factors in determining a company's position in the market.

0 views • 31 slides

The capital market and money market serve different purposes in the financial world. While the capital market provides funds for long-term investments in securities like stocks and debentures, the money market deals with short-term borrowing and lending of funds. The capital market acts as a middlem

0 views • 4 slides

Analyze the impact of RWE analytics on market access and reimbursement strategies, highlighting its role in providing evidence that supports value-driven healthcare and drug approval processes.\n

1 views • 5 slides

The field of oncology presents unique opportunities for advancing drug development through novel therapeutic modalities like immunotherapies, cell and gene therapies, and radioligand therapies. However, regulators, sponsors, and payers face criticism, often due to non-significant results in overall

0 views • 16 slides